According to a first aspect the invention relates to the use of fumaric acid derivatives selected from the group consisting of dialkyl fumarates, monoalkyl hydrogen fumarates, fumaric acid monoalkyl ester salts, fumaric acid monoamides, monoamido fumaric acid salts, fumaric acid diamides, monoalkyl monoamido fumarates, carbocyclic and oxacarbocyclic oligomers of these compounds and mixtures thereof for preparing a drug for the treatment or prevention of cardiac insufficiency, in particular left ventricular insufficiency, myocardial infarction and angina pectoris. According to a second aspect the invention relates to the use of fumaric acid derivatives, selected from the group consisting of dialkyl fumarates, monoalkyl hydrogen fumarates, fumaric acid monoalkyl ester salts, fumaric acid monoamides, monoamido fumaric acid salts, fumaric acid diamides, monoalkyl monoamido fumarates, carbocyclic and oxacarbocyclic oligomers of these compounds and mixtures thereof for preparing a drug for the treatment of asthma and chronic obstructive pulmonary diseases, especially asthma caused by allergies, infections, analgesics, job conditions or physical effort, mixed forms of asthma, or asthma cardiale.

Title
Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
Application Number
10/571241
Publication Number
20070027076
Application Date
September 3, 2004
Publication Date
February 1, 2007
Inventor
Michael Tamm
Christian Zaugg
Hans Peter Strebel
Rajendra K Joshi
Agent
Legal Department
MA, US
Patent & Trademark Coordinator
MA, US
Assignee
Fumapham
IPC
A61K 31/19
A61K 31/198
A61K 31/573
A61K 38/04
A61K 38/06
A61K 38/08
A61K 38/10
A61K 38/16
View Original Source